BioSig Technologies Signs Three New Licensing Agreements with Mayo Clinic
26 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 26, 2019 (GLOBE NEWSWIRE) -- ·New areas of collaboration identified between Mayo Clinic and BioSig ·Focus on previously untapped arrhythmia treatments ...
BioSig Commences Clinical Trial Enrollment for PURE EP System
21 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
18 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Technologies Issues November 2019 Shareholder Letter
14 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 14, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Technologies Invests in Union College’s Internship Program
07 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 07, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
Sasha Gentling, CFA Joins BioSig as Director of Business Development
06 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Appoints Andrew Ballou as Vice President of Investor Relations
29 oct. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 29, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Opens a Technology Development Office in Rochester, MN
15 oct. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 15, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy
10 oct. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 10, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig to Present Clinical Observations at Venice Arrhythmias 2019
30 sept. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...